Pollescas, Kenth Ivan .
HRN: 22-11-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/25/2022
11/01/2022
PO
3 Ml
Q12
T/C PSGN
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes